Invasive spindle-cell rhabdomyosarcoma with osteolysis in a dog: case report and literature review. (March 2023)

• Record Type: Journal Article
• Authors: Shi, Junchao; Gao, Rui; Zhang, Jing; Xu, Rongyi; Jia, Qianhan; Ma, Ying; Lu, Huijun; Zhao, Kui; Gao, Feng; He, Wenqi
• Is Part Of: Journal of veterinary diagnostic investigation. Volume 35:Number 2(2023)
• Page Start: 168
• Page End: 172
• Publication Date: 2023-03
• Subjects: canine -- desmin -- myoD1 -- myogenin -- osteolysis -- rhabdomyosarcoma -- spindle cell; Veterinary medicine -- Diagnosis -- Periodicals; 636.0896075
• DOI: 10.1177/10406387221147319
• Languages: English
• ISSNs: 1040-6387

Abstract

Rhabdomyosarcoma (RMS), a malignant mesenchymal neoplasm derived from skeletal muscle, is relatively rare in both human and veterinary medicine. Here we report an unusual case of invasive spindle-cell RMS (SCRMS) with bone infiltration and pathologic fracture in a 3.5-y-old intact female Bulldog. Radiographically, a large, predominantly osteolytic mass in the tibia and fibula of the left hindlimb had features typical of a malignant primary bone tumor. Clinically, osteosarcoma was suspected, and the leg was amputated. Histologically, the mass was composed of loosely interwoven spindle-cell fascicles; tumor cells were fusiform with cigar-shaped nuclei and abundant eosinophilic cytoplasm. The neoplastic cells were strongly immunopositive for vimentin, muscle-specific actin, desmin, myogenin, and myoD1. Invasive SCRMS with osteolysis was diagnosed based on the histologic examination and immunohistochemical (IHC) stains. The dog was alive without any evidence of local recurrence or distant metastasis 18 mo post-surgery. RMS should be included in the differential diagnosis when osteolysis occurs; IHC staining confirmation is of great value for definitive diagnosis and treatment planning.